Reaction-based phosphorescent nanosensor for ratiometric and time-resolved luminescence imaging of fluoride in live cells

2015 ◽  
Vol 51 (64) ◽  
pp. 12839-12842 ◽  
Author(s):  
Shujuan Liu ◽  
Jie Zhang ◽  
Danfeng Shen ◽  
Hua Liang ◽  
Xiangmei Liu ◽  
...  

A two-channel phosphorescent nanosensor has been designed for use in ratiometric and time-resolved luminescence imaging of intracellular F−.

Author(s):  
Diana Spiegelberg ◽  
Jonas Stenberg ◽  
Pascale Richalet ◽  
Marc Vanhove

AbstractDesign of next-generation therapeutics comes with new challenges and emulates technology and methods to meet them. Characterizing the binding of either natural ligands or therapeutic proteins to cell-surface receptors, for which relevant recombinant versions may not exist, represents one of these challenges. Here we report the characterization of the interaction of five different antibody therapeutics (Trastuzumab, Rituximab, Panitumumab, Pertuzumab, and Cetuximab) with their cognate target receptors using LigandTracer. The method offers the advantage of being performed on live cells, alleviating the need for a recombinant source of the receptor. Furthermore, time-resolved measurements, in addition to allowing the determination of the affinity of the studied drug to its target, give access to the binding kinetics thereby providing a full characterization of the system. In this study, we also compared time-resolved LigandTracer data with end-point KD determination from flow cytometry experiments and hypothesize that discrepancies between these two approaches, when they exist, generally come from flow cytometry titration curves being acquired prior to full equilibration of the system. Our data, however, show that knowledge of the kinetics of the interaction allows to reconcile the data obtained by flow cytometry and LigandTracer and demonstrate the complementarity of these two methods.


2011 ◽  
Vol 100 (3) ◽  
pp. 475a
Author(s):  
James Werner ◽  
Peter Goodwin ◽  
Elizabeth Phipps ◽  
Patrick Cutler ◽  
Diane Lidke ◽  
...  

2019 ◽  
Vol 91 (6) ◽  
pp. 3869-3876 ◽  
Author(s):  
Lei Li ◽  
Changcheng Zhang ◽  
Peng Wang ◽  
Aoxue Wang ◽  
Jiasheng Zhou ◽  
...  

2017 ◽  
Vol 140 ◽  
pp. 407-416 ◽  
Author(s):  
Hua Ma ◽  
Bo Song ◽  
Yuanxiu Wang ◽  
Chaolong Liu ◽  
Xin Wang ◽  
...  

2019 ◽  
Author(s):  
Gazzi, Thais ◽  
Benjamin Brennecke ◽  
Kenneth Atz ◽  
Claudia Korn ◽  
David Sykes ◽  
...  

Cannabinoid type 2 receptor (CB<sub>2</sub>R) is a fundamental part of the endocannabinoid signaling system (eCB system), and is known to play an important role in tissue injury, inflammation, cancer and pain. In stark contrast to its significance, the underlying signaling mechanisms and tissue expression profiles are poorly understood. Due to its low expression in healthy tissue and lack of reliable chemical tools, CB<sub>2</sub>R visualization in live cells remains uncharted. Here we report the development of a drug derived toolbox of highly potent, CB<sub>2</sub>R-selective fluorescent probes based on reverse design. Extensive validation in several applications such as CB<sub>2</sub>R detection in flow cytometry and time-resolved imaging, and the development of a novel fluorescent-based TR-FRET assay to generate kinetic and equilibrium binding data demonstrate the high versatility of our toolbox. These probes are the first to preserve affinity and efficacy in both human and mouse CB<sub>2</sub>R, a crucial aspect for preclinical translatability, and to enable imaging of CB2R internalization in living cells using confocal microscopy.


Sign in / Sign up

Export Citation Format

Share Document